help  | faq  | software  | BAR

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 201 to 300 out of 306 for cell

Category restricted to UniProtFeature (x)

0.225s

Categories

Category: UniProtFeature
Type Details Score
UniProt Feature
Begin: 529
Description: In wol-2; retardation of the primary root growth with reduced cell number and exclusive xylem differentiation within the vascular tissue associated with abnormal vascular asymmetric cell divisions, and impaired cytokinin-binding ability.
Type: mutagenesis site
End: 529
UniProt Feature
Begin: 779
Description: In rsw1-45; abnormal embryos, short and stout plants, and reduced crystalline cellulose deposition in cell walls.
Type: mutagenesis site
End: 779
UniProt Feature
Begin: 38
Description: Extra divisions outside the stomatal cell lineage and reduced phosphorylation by ASK7; when associated with A-44.
Type: mutagenesis site
End: 38
UniProt Feature
Begin: 44
Description: Extra divisions outside the stomatal cell lineage and reduced phosphorylation by ASK7; when associated with A-38.
Type: mutagenesis site
End: 44
UniProt Feature
Begin: 95
Description: No prenylation and loss of cell membrane and Golgi apparatus attachment leading to cytoplasmic subcellular localization.
Type: mutagenesis site
End: 95
UniProt Feature
Begin: 197
Description: Reduced cell membrane localization. Cytosolic only; when associated with 179-A-A-180 or 179-A-A-180 and 209-A-A-210 and 218-A-A-219.
Type: mutagenesis site
End: 198
UniProt Feature
Begin: 209
Description: Reduced cell membrane localization. Cytosolic only; when associated with 218-A-A-219 or 179-A-A-180 and 197-A-A-198 and 218-A-A-219.
Type: mutagenesis site
End: 210
UniProt Feature
Begin: 34
Description: Loss of TIR domain homodimerization. Loss of TIR domain heterodimerization with RRS1. Loss of cell death induction.
Type: mutagenesis site
End: 34
UniProt Feature
Begin: 222
Description: In BASL_d41; impaired polarization at the cell cortex but accumulation in cytoplasm and nucleus. Cannot complement disruption phenotype.
Type: mutagenesis site
End: 262
UniProt Feature
Begin: 419
Description: In kup2-1; also named shy3-1 induces a short hypocotyl phenotype and decrease in cell expansion in shoot tissues.
Type: mutagenesis site
End: 419
UniProt Feature
Begin: 262
Description: Normal cell death induction in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of RKS1 and RPP13L4/ZAR1.
Type: mutagenesis site
End: 262
UniProt Feature
Begin: 219
Description: Normal cell death induction in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of RKS1 and RPP13L4/ZAR1.
Type: mutagenesis site
End: 219
UniProt Feature
Begin: 247
Description: Normal cell death induction in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of RKS1 and RPP13L4/ZAR1.
Type: mutagenesis site
End: 247
UniProt Feature
Begin: 185
Description: In rhd3-2/fra4; reduced root and root hair length. Strong reduction in the cell wall thickness of fibers and vessels.
Type: mutagenesis site
End: 185
UniProt Feature
Begin: 591
Description: In acd6-1; gain-of-function leading to SA-dependent spontaneous cell death and increased disease resistance. Stronger accumulation at the plasma membrane.
Type: mutagenesis site
End: 591
UniProt Feature
Begin: 113
Description: In akr2a-3; small plants with small and curled rosette leaves, as well as delayed flowering, especially in chilling temperature conditions.Abnormal abaxial epidermal wavy cell shape and absence of cell boundaries between the neighboring surface cells. Impaired interaction with APX3.
Type: mutagenesis site
End: 113
UniProt Feature
Begin: 25
Description: In akr2a-1; small plants with small and curled rosette leaves, as well as delayed flowering, especially in chilling temperature conditions. Abnormal abaxial epidermal wavy cell shape and absence of cell boundaries between the neighboring surface cells. Impaired interaction with APX3.
Type: mutagenesis site
End: 25
UniProt Feature
Begin: 78
Description: Impaired polymerization leading to an altered polar localization and abnormal cell division planes in the root; when associated with D-29.
Type: mutagenesis site
End: 78
UniProt Feature
Begin: 962
Description: In iyo-1; delayed onset of cell differentiation in all meristems, but no effect on the binding to NRPB3 and NRPB10L.
Type: mutagenesis site
End: 962
UniProt Feature
Begin: 124
Description: Normal uridylylation and cell death induction in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of RKS1 and RPP13L4/ZAR1.
Type: mutagenesis site
End: 124
UniProt Feature
Begin: 359
Description: Lost ability to trigger cell death in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of PBL2 and RKS1.
Type: mutagenesis site
End: 359
UniProt Feature
Begin: 33
Description: Loss of TIR domain homodimerization. Loss of TIR domain heterodimerization; when associated with A-25 in RRS1. Loss of cell death induction.
Type: mutagenesis site
End: 33
UniProt Feature
Begin: 308
Description: In rpd1-1; impaired in adventitious root formation and maintenance of callus cell proliferation at the restrictive temperature of 28 degrees Celsius.
Type: mutagenesis site
End: 308
UniProt Feature
Begin: 1
Description: Reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 10
UniProt Feature
Begin: 400
Description: Impaired photoreduction in vitro, but not in vivo or whole cell extracts, due to an alternative electron transport that involves small metabolites.
Type: mutagenesis site
End: 400
UniProt Feature
Begin: 78
Description: In gl3-sst; oddly shaped trichomes with more endoreplication, disturbed cell wall development and abnormal nuclear shape. Reduced interactions with MYB0/GL1 and TTG1.
Type: mutagenesis site
End: 78
UniProt Feature
Begin: 29
Description: Impaired polymerization leading to an altered polar localization and abnormal cell division planes in the root; when associated with A-78 or R-78.
Type: mutagenesis site
End: 29
UniProt Feature
Begin: 405
Description: Dysfunction of the two-component signaling pathway leading to defects in procambial cell maintenance and proliferation, as well as the absence of secondary growth.
Type: mutagenesis site
End: 405
UniProt Feature
Begin: 301
Description: In wol-1; locked in the phosphoprotein phosphatase active form, retardation of the primary root growth with reduced cell number and exclusive xylem differentiation within the vascular tissue associated with abnormal vascular asymmetric cell divisions, impaired metaxylem and phloem differentiation, and reduced cytokinin-binding ability leading to impaired kinase activity and cytokinin-mediated activation.
Type: mutagenesis site
End: 301
UniProt Feature
Begin: 237
Description: In delta-31; reduced MPK3/MPK6 mediated phosphorylation and excessive numbers of asymmetric cell divisions in leaves epidermis leading to the creation of cells with meristemoid morphology.
Type: mutagenesis site
End: 267
UniProt Feature
Begin: 283
Description: In rol1-2; Abolishes dehydratase activity in vitro (PubMed:16766693). Induces aberrant accumulation of flavonols leading to alterations in plant growth and cell shape formation (PubMed:18567791, PubMed:18757557).
Type: mutagenesis site
End: 283
UniProt Feature
Begin: 305
Description: In spr3; right-handed helical growth due to anisotropic cell expansion and abnormal microtubule branching characterized by wider and divergently distributed nucleating angles. Impaired interaction with GCP3.
Type: mutagenesis site
End: 305
UniProt Feature
Begin: 597
Description: Impaired interaction with RKS1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 597
UniProt Feature
Begin: 544
Description: Impaired interaction with RKS1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 544
UniProt Feature
Begin: 132
Description: Loss of kinase activity and constitutive localization to both punctate structures and microtubules, leading to disturbed cortical microtubule organization and polarized cell expansion; when associated with R-42.
Type: mutagenesis site
End: 132
UniProt Feature
Begin: 42
Description: Loss of kinase activity and constitutive localization to both punctate structures and microtubules, leading to disturbed cortical microtubule organization and polarized cell expansion; when associated with N-132.
Type: mutagenesis site
End: 42
UniProt Feature
Begin: 27
Description: Impaired interaction with RPP13L4/ZAR1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 27
UniProt Feature
Begin: 35
Description: Impaired interaction with RPP13L4/ZAR1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 35
UniProt Feature
Begin: 469
Description: In til1-4; lengthening of the cell cycle during embryo development and alters cell type patterning of the hypophyseal lineage in the root, leading to a displacement of the root pole from its normal position on top of the suspensor. Slow growing roots, slightly delayed flowering, altered floral phyllotaxis, a reduced number of ovules, abnormally developing ovules, and reduced fertility.
Type: mutagenesis site
End: 469
UniProt Feature
Begin: 9
Description: Reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-10 and A-14.
Type: mutagenesis site
End: 9
UniProt Feature
Begin: 136
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 136
UniProt Feature
Begin: 10
Description: Reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-9 and A-14.
Type: mutagenesis site
End: 10
UniProt Feature
Begin: 152
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 152
UniProt Feature
Begin: 150
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 150
UniProt Feature
Begin: 154
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 154
UniProt Feature
Begin: 14
Description: Reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-9 and A-10.
Type: mutagenesis site
End: 14
UniProt Feature
Begin: 240
Description: Abolished interaction with uridylylated PBL2 and abolished ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 240
UniProt Feature
Begin: 69
Description: Abolished interaction with uridylylated PBL2 and abolished ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 69
UniProt Feature
Begin: 231
Description: Abolished interaction with uridylylated PBL2 and abolished ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 231
UniProt Feature
Begin: 232
Description: Abolished interaction with uridylylated PBL2 and abolished ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc).
Type: mutagenesis site
End: 232
UniProt Feature
Begin: 404
Description: In PT; shows pleiotropic phenotypes, including altered shoot apical meristems, increased cell proliferation, polycotyly, constitutive photomorphogenesis, early flowering time, increased levels of endogenous cytokinin, and increased cyclin cycD3 expression.
Type: mutagenesis site
End: 404
UniProt Feature
Begin: 490
Description: In cre1-1; impaired histidine-kinase receptor activity and reduced responses to cytokinins, including rapid cell proliferation and shoot formation in tissue culture, repression of sulfate uptake, retardation of the primary root growth, no production of lateral roots and enhanced formation of adventitious roots associated with impaired auxin basipetal transport, as well as reduced cell number within the vascular tissues in roots.
Type: mutagenesis site
End: 490
UniProt Feature
Begin: 816
Description: Lost ability to trigger cell death in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of PBL2 and RKS1. Impaired interactions with RKS1, ZED1, ZRK3, ZRK6 and ZRK15.
Type: mutagenesis site
End: 816
UniProt Feature
Begin: 171
Description: In delta-49; reduced MPK3/MPK6 mediated phosphorylation and excessive numbers of asymmetric cell divisions in leaves epidermis leading to the creation of cells with meristemoid morphology, but fails to produce stomata.
Type: mutagenesis site
End: 220
UniProt Feature
Begin: 545
Description: In amp1-7; weak allele showing some pleiotropic phenotypes, including altered shoot apical meristem, increased cell proliferation, serrated leaves prior to full expansion, early flowering and increased levels of endogenous cytokinin.
Type: mutagenesis site
End: 545
UniProt Feature
Begin: 825
Description: Impaired interaction with RKS1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-839.
Type: mutagenesis site
End: 825
UniProt Feature
Begin: 839
Description: Impaired interaction with RKS1 and reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-825.
Type: mutagenesis site
End: 839
UniProt Feature
Begin: 339
Description: In pmr6-5; strong powdery mildew resistance, cell walls of plants are enriched for pectins with a lower degree of esterification and an alteration in the H bonding environment of cellulose microfibrils.
Type: mutagenesis site
End: 339
UniProt Feature
Begin: 140
Description: In pmr6-1; strong powdery mildew resistance, cell walls of plants are enriched for pectins with a lower degree of esterification and an alteration in the H bonding environment of cellulose microfibrils.
Type: mutagenesis site
End: 140
UniProt Feature
Begin: 149
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-297.
Type: mutagenesis site
End: 149
UniProt Feature
Begin: 297
Description: Reduced oligomerization activity associated with a reduced ability to mediate cell death as well as an increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc); when associated with A-149.
Type: mutagenesis site
End: 297
UniProt Feature
Begin: 324
Description: Impaired photoreduction in vitro, but not in vivo or in whole cell extracts, due to an alternative electron transport that involves small metabolites. Abolished intra-protein electron transfer cascade and impaired conformational change upon photoexcitation.
Type: mutagenesis site
End: 324
UniProt Feature
Begin: 163
Description: In srd2-1; temperature sensitive plants with severe suppression of seedling growth and impaired shoot redifferentiation in root explants at 27 degrees Celsius but not at 22 degrees Celsius, however, reduced lateral root formation at any temperature. Loss of reinitiation of the progression of the cell cycle at the restrictive temperature (e.g. 27 degrees Celsius) accompanied with a global reduction in protein tyrosine phosphorylation and impaired small-nuclear RNA transcription. Reduced trichome branching, disordered vascular network and abnormal guard cell shapes are also observed. Altered organization of cells in root primordia, with abnormal apical/basal and radial axes, and persistance of primordial cell division resulting in the formation of abnormal hemispherical laterals.
Type: mutagenesis site
End: 163
UniProt Feature
Begin: 214
Description: Ectopic stomata formation and increased accumulation; when associated with A-193, A-211, A-219 and A-255. Ectopic asymmetric cell divisions, but fails to produce stomata, and reduced repression by osmotic stress (e.g. mannitol); when associated with A-193, A-211 and A-219.
Type: mutagenesis site
End: 214
UniProt Feature
Begin: 211
Description: Ectopic stomata formation and increased accumulation; when associated with A-193, A-214, A-219 and A-255. Ectopic asymmetric cell divisions, but fails to produce stomata, and reduced repression by osmotic stress (e.g. mannitol); when associated with A-193, A-214 and A-219.
Type: mutagenesis site
End: 211
UniProt Feature
Begin: 219
Description: Ectopic stomata formation and increased accumulation; when associated with A-193, A-211, A-214 and A-255. Ectopic asymmetric cell divisions, but fails to produce stomata, and reduced repression by osmotic stress (e.g. mannitol); when associated with A-193, A-211 and A-214.
Type: mutagenesis site
End: 219
UniProt Feature
Begin: 74
Description: In sol2; stem cell proliferation leading to large meristems, increased carpel number, and slightly shorter roots. Suppresses the short root phenotype of transgenic plants constitutively overexpressing the CLE19 gene. Enhanced resistance to CLV3 peptide that inhibits root growth.
Type: mutagenesis site
End: 74
UniProt Feature
Begin: 309
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 309
UniProt Feature
Begin: 159
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 159
UniProt Feature
Begin: 327
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 327
UniProt Feature
Begin: 332
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-336 and A-340.
Type: mutagenesis site
End: 332
UniProt Feature
Begin: 94
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 94
UniProt Feature
Begin: 91
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 91
UniProt Feature
Begin: 217
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 217
UniProt Feature
Begin: 193
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 193
UniProt Feature
Begin: 149
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 149
UniProt Feature
Begin: 324
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 324
UniProt Feature
Begin: 308
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 308
UniProt Feature
Begin: 33
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 33
UniProt Feature
Begin: 235
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 235
UniProt Feature
Begin: 340
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332 and A-336.
Type: mutagenesis site
End: 340
UniProt Feature
Begin: 84
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 84
UniProt Feature
Begin: 320
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 320
UniProt Feature
Begin: 197
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 197
UniProt Feature
Begin: 336
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332 and A-340.
Type: mutagenesis site
End: 336
UniProt Feature
Begin: 29
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 29
UniProt Feature
Begin: 331
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-332, A-336 and A-340.
Type: mutagenesis site
End: 331
UniProt Feature
Begin: 79
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 79
UniProt Feature
Begin: 163
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 163
UniProt Feature
Begin: 145
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 145
UniProt Feature
Begin: 19
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 19
UniProt Feature
Begin: 141
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 141
UniProt Feature
Begin: 86
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-233, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 86
UniProt Feature
Begin: 233
Description: Reduced ASK7-mediated phosphorylation, enhanced stabilization at the plasma membrane and increased cell division; when associated with A-19, A-29, A-33, A-79, A-84, A-86, A-91, A-94, A-141, A-145, A-149, A-159, A-163, A-193, A-197, A-217, A-235, A-308, A-309, A-320, A-324, A-327, A-331, A-332, A-336 and A-340.
Type: mutagenesis site
End: 233
UniProt Feature
Begin: 193
Description: Unable to rescue disruption phenotype. Ectopic stomata formation and increased accumulation; when associated with A-211, A-214, A-219 and A-255. Ectopic asymmetric cell divisions, but fails to produce stomata, and reduced repression by osmotic stress (e.g. mannitol); when associated with A-211, A-214 and A-219.
Type: mutagenesis site
End: 193
UniProt Feature
Begin: 110
Description: In rid2-1; temperature-sensitive mutant with altered reactivation of cell proliferation in the hypocotyl stele during callus formation from hypocotyl and root explants above 28 degrees Celsius. Impaired initiation of lateral root primordia formation. Exhibits abnormalities in the formation of the root apical meristem (RAM). Various (acute and non-acute) temperature sensitive inhibitory effects on different aspects of cell proliferation leading to reduced roots and leaves development during seedling growth. Nucleolar vacuolation and excessive accumulation of various intermediates of pre-rRNA processing. Abnormally swollen cells during culture on callus-inducing medium (CIM) with extraordinarily large nucleoli.
Type: mutagenesis site
End: 110
UniProt Feature
Begin: 253
Description: Increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc) in vascular tissues. Lost ability to trigger cell death in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of PBL2 and RKS1. Impaired Xanthomonas campestris effector AvrAC/XopAC-mediated uridylylation; when associated with A-254.
Type: mutagenesis site
End: 253
UniProt Feature
Begin: 254
Description: Increased sensitivity to the pathogenic biotrophic bacteria Xanthomonas campestris pv. campestris (Xcc) in vascular tissues. Lost ability to trigger cell death in response to the Xanthomonas campestris effector XopAC/AvrAC in the presence of PBL2 and RKS1. Impaired Xanthomonas campestris effector AvrAC/XopAC-mediated uridylylation; when associated with A-253.
Type: mutagenesis site
End: 254
UniProt Feature
Begin: 340
Description: In alt2-1; severely sensitive to the intrastrand DNA cross-linking agent cisplatin (CDDP) and to the DNA cross-linking agent mitomycin C (MMC), enhanced tolerance to aluminum (Al), but impaired halting root growth in response to Al toxicity. Fails to halt cell cycle progression in the presence of DNA cross-linking agents.
Type: mutagenesis site
End: 340
UniProt Feature
Begin: 497
Description: In osz2; semi-dominant mutation with impaired proteolytic processing, and leading to an increased sensitivity to zinc Zn(2+) characterized by Zn-triggered reduced root elongation due to a defect in cell elongation, but an increase number of root hairs; this phenotype is suppressed by calcium Ca(2+) treatment. No obvious impact on pectin methylesterification.
Type: mutagenesis site
End: 497